Diagnostic Tests

Selected news for the healthcare topic - Diagnostic Tests, collected since 10/2017. This healthcare topic shares news with COVID-19, Infectious Disease, Coronavirus, Public Health, Molecular Diagnostics and hundreds of others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
10/14/2021 Embracing emerging technologies Healthcare IT News ... Kar tells Healthcare It News. Its efforts include the creation of Apollo 247, India’s only comprehensive digital health solution with 24-hour physician consultations, an online pharmacy with home delivery, online ordering for diagnostic tests and a secure personal health record system. Apollo Hospitals has also developed multiple clinical AI-based solutions in areas including cardiology, respiratory health, liver disease, antibiotic stewardship, breast cancer, COVID-19 scanners and predictors ...
10/13/2021 DAF Awards $30 Million Contract to Eurofins Genomics to Expand Oligonucleotide (DNA) Capacity for Diagnostic Testing tncontentexchange.com ... Department of Health and Human Services (HHS), awarded a $30 million contract to Eurofins Genomics US to build a new production facility and expanded capacity for the manufacturing of reagents used in COVID-19 diagnostic tests . The new facility will focus on the production of GMP grade synthetic DNA, also called oligonucleotides (oligos), for molecular diagnostic testing. Molecular testing is an extremely accurate method for identifying viruses and utilized by ...
10/13/2021 Chembio Diagnostics (NASDAQ:CEMI) Upgraded by Zacks Investment Research to “Hold” - Watch List News watchlistnews.com ... Investment Research from a “sell” rating to a “hold” rating in a research report issued on Monday, Zacks.com reports.According to Zacks, “CHEMBIO DIAGNOSTICS, INC. develops, manufactures, licenses and markets proprietary rapid diagnostic tests in the growing $5 billion point-of-care testing market. Chembio’s two FDA PMA-approved, CLIA-waived, rapid HIV tests are marketed in the U.S. by a third party company. Chembio markets its ...
10/13/2021 Chembio Diagnostics (NASDAQ:CEMI) Rating Increased to Hold at Zacks Investment Research - Ticker Report Ticker Report ... Investment Research from a “sell” rating to a “hold” rating in a research report issued on Monday, Zacks.com reports.According to Zacks, “CHEMBIO DIAGNOSTICS, INC. develops, manufactures, licenses and markets proprietary rapid diagnostic tests in the growing $5 billion point-of-care testing market. Chembio’s two FDA PMA-approved, CLIA-waived, rapid HIV tests are marketed in the U.S. by a third party company. Chembio markets its ...
10/13/2021 Global MRSA Testing Market to Grow with Launch of Advanced Diagnostic Techniques Such as Cepheid's Molecular-Based Diagnostic Test: Fortune Business Insights midlandweekly.com ... Insights Growing prevalence of MRSA infection worldwide will drive the global MRSA testing market, finds Fortune Business Insights in its report, titled “MRSA Testing Market Size, Share and Global Trend By Test Type (Molecular Diagnostic Tests , Immunodiagnostic Tests), By End User (Hospitals, Diagnostic & Pathology Centers, Research Institutes, Others), and Geography Forecast till 2026”. A comprehensive analysis of the expected market trends and crucial factors is also incorporated in the ...
10/12/2021 Health Care Heroes 2021: Jamila Smith-Young of UT Le Bonheur Pediatric Specialists The Business Journals ... major medical issues to mental struggles and chronic physical issues. A good doctor will nag you — and absolutely besiege you with calls, texts, and emails — about your annual checkups and age-related diagnostic tests .And, there’s a lot of behind-the-scenes elements to the medical field: organizations that advocate for a healthier community, administrations that run our local teaching hospitals and schools.During the past year ...
10/11/2021 A proof of concept study for the differentiation of SARS-CoV-2, hCoV-NL63, and IAV-H1N1 in vitro cultures using ion mobility spectrometry Nature Abstract Rapid, high-throughput diagnostic tests are essential to decelerate the spread of the novel coronavirus disease 2019 (COVID-19) pandemic. While RT-PCR tests performed in centralized laboratories remain the gold standard, rapid point-of-care antigen tests might provide faster results. However, they are associated with markedly reduced sensitivity. Bedside breath gas analysis of volatile organic compounds detected by ion mobility spectrometry (IMS) may enable a quick and ...
10/11/2021 Dr. Scott Gottlieb says Merck's Covid pill ‘can make a real difference’ CNBC ... told CNBC's "The News with Shepard Smith" Merck's pill is part of an "overall, significant improvement in our therapeutic toolbox against this virus, not just with vaccines and therapeutics, but also with more accessible diagnostic tests ." Host Shepard Smith also asked Gottlieb about masking rules across the country. Gottlieb told Smith that he thinks decisions will be made at a local level and noted the varying prevalence of the delta ...
10/11/2021 Readers Write: Why Patient Control of their Own Data is the Key to Health Equity HISTalk ... requirements. They may have a provider that “data hoards” to prevent patients from switching to a competitor. Patients may not be able to access all their medical records. Patients particularly struggle to access diagnostic tests from labs, which is a serious problem since diagnostic test results are the most critical information clinicians use when devising treatment plans. Ensuring patients can easily and securely access their digital health records increases ...
10/11/2021 Quidel (NASDAQ:QDEL) Lowered to Strong Sell at Zacks Investment Research - Slater Sentinel slatersentinel.com Zacks Investment Research lowered shares of Quidel (NASDAQ:QDEL) from a hold rating to a strong sell rating in a report released on Thursday morning, Zacks.com reports.According to Zacks, “Quidel Corp. discovers, develops, manufactures and markets point-of-care, rapid diagnostic tests for detection of medical conditions and illnesses. These products provide accurate, rapid and cost-effective diagnostic information for acute and chronic conditions that affect women’s health ...
10/10/2021 The Worldwide In-Vitro Diagnostic Tests Market Report 2021 directprimarycare.com The Worldwide In-Vitro Diagnostic Tests Market Report 2021 – ResearchAndMarkets.com September 01, 2021 09:49 AM Eastern Daylight Time DUBLIN–( BUSINESS WIRE )–The “The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition” report has been added to ResearchAndMarkets.com’s offering “The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition” The most essential report on the IVD industry, this 1,500-plus page report has provided reliable ...
10/9/2021 Genetic variation of Plasmodium falciparum histidine-rich protein 2 and 3 in Assosa zone, Ethiopia: its impact on the performance of malaria rapid diagnostic tests biomedcentral.com Research - Open Access - [Published:] Genetic variation of Plasmodium falciparum histidine-rich protein 2 and 3 in Assosa zone, Ethiopia: its impact on the performance of malaria rapid diagnostic tests 394 Rapid diagnostic tests (RDT) are commonly used for the diagnosis of malaria caused by Plasmodium falciparum. However, false negative results of RDT caused by genetic variation of P. falciparum histidine-rich protein 2 and 3 genes (pfhrp2/3) threaten existing malaria ...
10/9/2021 5 Top Stock Gainers Friday: ChemoCentryx, Plug Power, Quidel TheStreet ... at $27. Plug "is one of the few renewable-energy companies that offers an alternative to the mainstream alternatives," the analyst said. Shares of Quidel ( QDEL ) - Get Quidel Corporation Report climbed after the medical diagnostic tests producer estimated a rise in third-quarter revenue , tied to its rapid Covid-19 tests. Quidel expects expects total revenue in the quarter to range between $505 million and $510 million, an increase of ...
10/9/2021 Quidel (NASDAQ:QDEL) Cut to Strong Sell at Zacks Investment Research - Stock Observer thestockobserver.com Quidel (NASDAQ:QDEL) was downgraded by Zacks Investment Research from a “hold” rating to a “strong sell” rating in a report released on Thursday, Zacks.com reports.According to Zacks, “Quidel Corp. discovers, develops, manufactures and markets point-of-care, rapid diagnostic tests for detection of medical conditions and illnesses. These products provide accurate, rapid and cost-effective diagnostic information for acute and chronic conditions that affect women’s ...
10/9/2021 Quidel (NASDAQ:QDEL) Rating Lowered to Strong Sell at Zacks Investment Research - Transcript Daily transcriptdaily.com ... a “hold” rating to a “strong sell” rating in a note issued to investors on Thursday, Zacks.com reports.According to Zacks, “Quidel Corp. discovers, develops, manufactures and markets point-of-care, rapid diagnostic tests for detection of medical conditions and illnesses. These products provide accurate, rapid and cost-effective diagnostic information for acute and chronic conditions that affect women’s health throughout the phases of their lives including ...
10/8/2021 COVID-19 Update for South Sudan - 7 October 2021 reliefweb.int ... for vaccinationLack of funding is resulting in closure of isolation facilities, cessation of sample collection and testing, surveillance activities, including contact tracing, points of entry, etc.Laboratory testing- Partners started using antigen rapid diagnostic tests on symptomatic cases.Awaiting results to be submitted, expected to significantly increase the number of confirmed COVID-19 cases - Partners can pick up test kits, printed registers and protocols, and request for training from ...
10/8/2021 Stocks making the biggest moves premarket: Tesla, Quidel, Chubb and more CNBC ... to a chromosomal abnormality in a single patient. The hold will be in place until an investigation is completed. Quidel (QDEL) – Quidel stock rallied 6.1% in premarket trading after the maker of rapid diagnostic tests reported more than $500 million in quarterly revenue, well above analyst projections. Growth was primarily driven by Covid-19 related revenue. Chubb (CB) – Chubb is buying the Asia Pacific and Turkey businesses of ...
10/8/2021 Medtech in a Minute: Boston Scientific's 3rd Billion-Dollar Deal in 2021 & More Big News MDDI ... of 2021] Francis Collins has led the National Institutes of Health during the historic COVID-19 pandemic, during which the NIH received almost $4.9 billion to date to fund important COVID-19 research on diagnostic tests , vaccines, and treatments, according to the agency’s website . And during his 12-year stint he established initiatives to tackle some of the most pressing health issues. Collins plans to return to his lab ...
10/8/2021 Quidel Stock Higher on Estimated Revenue Rise Tied to Covid Rapid Tests - TheStreet TheStreet Shares of Quidel ( QDEL ) - Get Quidel Corporation Report are higher after the producer of medical diagnostic tests estimated a rise in third-quarter revenue, tied to its rapid Covid-19 tests. The San Diego company said it expects total revenue in the quarter to range between $505 million and $510 million, an increase of 6% to 7% from a year earlier. "In the third quarter of 2021, we saw a ...
10/8/2021 5 Top Stock Gainers for Friday: ChemoCentryx, Plug Power, Quidel TheStreet ... at $27. Plug "is one of the few renewable-energy companies that offers an alternative to the mainstream alternatives," the analyst said. Shares of Quidel ( QDEL ) - Get Quidel Corporation Report climbed after the medical diagnostic tests producer estimated a rise in third-quarter revenue , tied to its rapid Covid-19 tests. Quidel expects expects total revenue in the quarter to range between $505 million and $510 million, an increase of ...